Experience of using gene replacement therapy with Zolgensma® (onasemnogene abeparvovec) in real clinical practice in Russia Autor S. B. Artemyeva, Yu. O. Papina, O. A. Shidlovskaya, A. V. Monakhova, D. V. Vlodavets

Získat plný text

Functional class criteria identification in patients with spinal muscular atrophy 5q Autor Yu. O. Papina, E. A. Melnik, E. D. Belousova, S. B. Artemyeva, A. V. Monakhova, O. A. Shidlovskaya, I. V. Shulyakova, D. V. Vlodavets

Získat plný text

Approaches to pathogenetic therapy of spinal muscular atrophy in children and newborns Autor S. B. Artemyeva, O. A. Shidlovskaya, Yu. O. Papina, A. V. Monakhova, I. V. Shulyakova, E. D. Belousova, O. Yu. Germanenko, D. V. Vlodavets

Získat plný text

The efficacy and safety of nusinersen within the expanded access program in Russia Autor S. B. Artemieva, L. M. Kuzenkova, E. S. Ilyina, Yu. A. Kursakova, L. M. Kolpakchi, E. Yu. Sapego, A. A. Golenko, S. G. Popovich, D. V. Parshin, O. A. Shidlovskaya, Yu. O. Papina, A. V. Monakhova, D. V. Vlodavets

Získat plný text